Published in Gastroenterology on July 01, 2006
Humoral immune responses of type 1 diabetes patients to Mycobacterium avium subsp. paratuberculosis lend support to the infectious trigger hypothesis. Clin Vaccine Immunol (2007) 1.22
Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberculosis with type-1 but not type-2 diabetes mellitus. PLoS One (2009) 1.06
Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease? PLoS Pathog (2009) 1.02
Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS One (2009) 0.99
Systems biology analysis of gene expression during in vivo Mycobacterium avium paratuberculosis enteric colonization reveals role for immune tolerance. PLoS One (2012) 0.95
Ulcerative colitis and Crohn's disease: is Mycobacterium avium subspecies paratuberculosis the common villain? Gut Pathog (2010) 0.94
Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J Clin Immunol (2008) 0.90
Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. Immun Ageing (2011) 0.84
Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol (2011) 0.81
Sex differences associated with primary biliary cirrhosis. Clin Dev Immunol (2012) 0.80
Specific IgG response against Mycobacterium avium paratuberculosis in children and adults with Crohn's disease. PLoS One (2013) 0.80
Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. Auto Immun Highlights (2011) 0.79
Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis. Auto Immun Highlights (2012) 0.78
Bioinformatic and immunological analysis reveals lack of support for measles virus related mimicry in Crohn's disease. BMC Med (2014) 0.77
In search of desire: mimicry, MAP, and Crohn's disease. Gastroenterology (2006) 0.76
Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis? World J Gastroenterol (2012) 0.76
Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease. World J Gastroenterol (2008) 0.76
Molecular mimicry, inflammatory bowel disease, and the vaccine safety debate. BMC Med (2014) 0.76
Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature. Tuberc Res Treat (2012) 0.75
Current status of Mycobacterium avium subspecies paratuberculosis infection in animals & humans in India: What needs to be done? Indian J Med Res (2016) 0.75
Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet (2007) 13.74
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Diagnosis and management of autoimmune hepatitis. Hepatology (2010) 5.27
Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet (2008) 4.96
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology (2004) 4.45
The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology (2002) 4.20
ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr (2009) 4.11
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A (2009) 3.49
A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology (2007) 3.37
Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut (2011) 3.11
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology (2007) 2.97
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet (2005) 2.93
Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81
Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology (2006) 2.63
Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One (2013) 2.50
Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease. Clin Chim Acta (2010) 2.31
Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology (2014) 2.29
Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc (2004) 2.27
Low serum vitamin D levels are associated with severe histological features and poor response to therapy in patients with autoimmune hepatitis. Dig Dis Sci (2014) 2.06
Association of DLG5 R30Q variant with inflammatory bowel disease. Eur J Hum Genet (2005) 1.84
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology (2012) 1.83
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology (2002) 1.77
Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol (2006) 1.70
Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology (2007) 1.68
Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut (2010) 1.61
Serial circulating markers of inflammation in biliary atresia--evolution of the post-operative inflammatory process. Hepatology (2007) 1.61
Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigue. J Soc Integr Oncol (2009) 1.61
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol (2004) 1.54
Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis. Hepatology (2010) 1.51
Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial. BMJ (2012) 1.51
The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol (2008) 1.50
How clinical and research failures lead to suboptimal prescribing: the example of chronic gout. BMJ (2011) 1.49
Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol (2006) 1.49
Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47
Diagnosing small bowel malabsorption: a review. Intern Emerg Med (2012) 1.45
Anorexia nervosa in gastrointestinal practice. Eur J Gastroenterol Hepatol (2004) 1.44
Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up. Gastroenterology (2008) 1.43
Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children. Pediatr Transplant (2012) 1.38
European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis (2008) 1.34
Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol (2008) 1.34
Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. Am J Hum Genet (2003) 1.32
Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology (2006) 1.30
Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology (2006) 1.29
Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women. Breast Cancer Res Treat (2007) 1.27
Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. JPEN J Parenter Enteral Nutr (2010) 1.27
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis. J Hepatol (2002) 1.24
Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis (2011) 1.22
Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease. Hum Mol Genet (2010) 1.21
Traumatic grief among adolescents exposed to a peer's suicide. Am J Psychiatry (2004) 1.19
Autoimmune hepatitis: a comprehensive review. J Autoimmun (2012) 1.16
The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol (2007) 1.16
The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol (2008) 1.15
Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23. Breast Cancer Res Treat (2004) 1.15
Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol (2011) 1.14
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
The management of enterocutaneous fistula in a regional unit in the United kingdom: a prospective study. Dis Colon Rectum (2010) 1.13
Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun (2005) 1.13
Glycoprotein 2 antibodies in inflammatory bowel disease: no association with disease phenotype? J Pediatr Gastroenterol Nutr (2013) 1.12
Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis study. Inflamm Bowel Dis (2006) 1.11
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology (2010) 1.10
Predictors and correlates of high levels of depression and anxiety symptoms among children at age 10. J Am Acad Child Adolesc Psychiatry (2006) 1.09
Autoimmune hepatitis. J Pediatr Gastroenterol Nutr (2009) 1.09
Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch. J Crohns Colitis (2013) 1.09
Student attitudes to psychiatry and their clinical placements. Med Teach (2011) 1.09
The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway. Hepatology (2012) 1.09
Sex stratification of an inflammatory bowel disease genome search shows male-specific linkage to the HLA region of chromosome 6. Eur J Hum Genet (2002) 1.08
Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol (2008) 1.07
The effect of sunlight on postoperative analgesic medication use: a prospective study of patients undergoing spinal surgery. Psychosom Med (2005) 1.07
Liver transplantation in children. J Hepatol (2006) 1.06
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis. J Hepatol (2004) 1.06
Biliary atresia. Semin Immunopathol (2009) 1.05
New platform technology for comprehensive serological diagnostics of autoimmune diseases. Clin Dev Immunol (2012) 1.04
Aetiopathogenesis of autoimmune hepatitis. J Autoimmun (2009) 1.04
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic. Hepatology (2005) 1.03
Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology (2006) 1.03
Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol (2007) 1.03
Evaluation of Crohn's disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. Eur Radiol (2013) 1.03
Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis (2009) 1.02
Collagen--emerging collagen based therapies hit the patient. Adv Drug Deliv Rev (2012) 1.02
Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology (2005) 1.02
Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study. Radiology (2009) 1.02
Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials (2004) 1.02
Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmun Rev (2011) 1.01
Pathogenesis of autoimmune hepatitis. Clin Liver Dis (2002) 1.00
Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials (2005) 1.00
Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis. Gastroenterology (2012) 0.99
New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies. Clin Chem (2009) 0.99
Autoimmune paediatric liver disease. World J Gastroenterol (2008) 0.99